Structural investigation of HIV-1 GP160 and gag-pol polyprotein recognition site with HIV-1 protease [PDF]
, 2022 HIV (human immunodeficiency virus) is an infectious virus that if left untreated can progress into AIDS (acquired immunodeficiency syndrome) and is a devastating and lethal disease with millions of related fatalities across the globe since its discovery.
core
Antibacterial, Anti-HIV-1 Protease and Cytotoxic Activities of Aqueous Ethanolic Extracts from Combretum Adenogonium Steud. Ex A. Rich (Combretaceae). [PDF]
, 2012 \ud \ud Records have shown that Combretum adenogonium Steud. Ex A. Rich (Combretaceae) is used in traditional medicine systems of several tribes in Tanzania. This study focused on the investigation of antibacterial activity, anti-HIV-1 protease activity,
Innocent Ester +11 more
core +1 more source
CARD8 inflammasome activation during HIV-1 cell-to-cell transmission
eLifeOur previous work demonstrated that CARD8 detects HIV-1 infection by sensing the enzymatic activity of the HIV protease, resulting in CARD8-dependent inflammasome activation (Kulsuptrakul et al., 2023).
Jessie Kulsuptrakul +2 more
doaj +1 more source
Analysis of the conformations of the HIV-1 protease from a large crystallographic data set
Data in Brief, 2017 The HIV-1 protease performs essential roles in viral maturation by processing specific cleavage sites in the Gag and Gag-Pol precursor polyproteins to release their mature forms.
Luigi Leonardo Palese
doaj +1 more source
Full length HIV-1 Gag determines protease inhibitor susceptibility within in vitro assays [PDF]
, 2010 OBJECTIVE: There is evidence that gag contributes to protease inhibitor susceptibility in treatment-experienced patients. Moreover, protease inhibitor resistance-associated mutations can arise in gag in the absence of protease mutations in vitro.
Gupta, R.K. +5 more
core +1 more source
PLoS ONE, 2012 IntroductionPersistent infection with GBV-C (GB Virus C), a non-pathogenic virus related to hepatitis C virus (HCV), prolongs survival in HIV infection. Two GBV-C proteins, NS5A and E2, have been shown previously to inhibit HIV replication in vitro.
Sarah L George +3 more
doaj +1 more source
In silico prediction of mutant HIV-1 proteases cleaving a target sequence.
PLoS ONE, 2014 HIV-1 protease represents an appealing system for directed enzyme re-design, since it has various different endogenous targets, a relatively simple structure and it is well studied. Recently Chaudhury and Gray (Structure (2009) 17: 1636-1648) published a
Jan H Jensen +3 more
doaj +1 more source
VirusesThe HIV-1 aspartic protease is an effective target for the treatment of HIV/AIDS. Current therapy utilizes a selection of nine protease inhibitors (PIs) in combination with other classes of antiretroviral drugs.
Dean Sherry +3 more
doaj +1 more source
Prediction and molecular field view of drug resistance in HIV-1 protease mutants
Scientific Reports, 2022 Conquering the mutational drug resistance is a great challenge in anti-HIV drug development and therapy. Quantitatively predicting the mutational drug resistance in molecular level and elucidating the three dimensional structure-resistance relationships ...
Baifan Wang, Yinwu He, Xin Wen, Zhen Xi
doaj +1 more source
Molecular monitoring of HIV-1 drug resistance in Ifakara HIV-1 Cohort, Tanzania [PDF]
, 2013 HIV-1 resistance is one of the problems affecting success of antiretroviral therapy programmes worldwide. Many studies on efficacy of ART programmes, specifically on drug resistance, have been conducted in developed countries but not in developing ...
Masimba, Pax Jessey
core +1 more source